• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNA topoisomerase dysfunction: a new goal for antitumor chemotherapy.

作者信息

Smith P J

机构信息

MRC Clinical Oncology, Cambridge, UK.

出版信息

Bioessays. 1990 Apr;12(4):167-72. doi: 10.1002/bies.950120405.

DOI:10.1002/bies.950120405
PMID:2159289
Abstract

Topoisomerase enzymes--found in prokaryotes to human cells--control conformational changes in DNA and aid the orderly progression of DNA replication, gene transcription and the separation of daughter chromosomes at cell division. Several classes of anti-cancer drugs are now recognised as topoisomerase poisons because of their ability to trap topoisomerase molecules on DNA as 'cleavable complexes'. Understanding how drugs generate such complexes and why they are toxic to actively growing cancer cells is a major challenge for the development of modern approaches to chemotherapy.

摘要

相似文献

1
DNA topoisomerase dysfunction: a new goal for antitumor chemotherapy.
Bioessays. 1990 Apr;12(4):167-72. doi: 10.1002/bies.950120405.
2
[Poisons of DNA topoisomerases I and II].[DNA拓扑异构酶I和II的毒物]
Bull Cancer. 1993 Nov;80(11):923-54.
3
A model for tumor cell killing by topoisomerase poisons.
Cancer Cells. 1990 Jan;2(1):23-7.
4
Emerging DNA topisomerase inhibitors as anticancer drugs.新型DNA拓扑异构酶抑制剂作为抗癌药物
Expert Opin Emerg Drugs. 2004 May;9(1):105-33. doi: 10.1517/eoed.9.1.105.32948.
5
[Topoisomerases I: new targets for the treatment of cancer and mechanisms of resistance].
Bull Cancer. 1998 Dec;Spec No:5-10.
6
Human DNA topoisomerase II: biochemistry and role in chemotherapy resistance (review).人类DNA拓扑异构酶II:生物化学及其在化疗耐药中的作用(综述)
Anticancer Res. 1996 Jul-Aug;16(4A):1867-80.
7
Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.E2F-1/DP-1转录因子复合物过表达后拓扑异构酶I和II抗癌药物的差异细胞毒性途径
Clin Cancer Res. 2000 Apr;6(4):1488-97.
8
DNA-topoisomerase inhibitors.DNA拓扑异构酶抑制剂
Curr Opin Oncol. 1993 Nov;5(6):1023-8.
9
Mechanism of action of DNA topoisomerase inhibitors.DNA拓扑异构酶抑制剂的作用机制。
Stem Cells. 1995 Jul;13(4):369-79. doi: 10.1002/stem.5530130408.
10
Human deoxyribonucleic acid topoisomerases: molecular targets of anticancer drugs.人类脱氧核糖核酸拓扑异构酶:抗癌药物的分子靶点。
Ann Clin Lab Sci. 1997 Nov-Dec;27(6):402-12.

引用本文的文献

1
MEASUREMENT of Protein 53 Diffusion Coefficient in Live HeLa Cells Using Raster Image Correlation Spectroscopy (RICS).使用光栅图像相关光谱法(RICS)测量活HeLa细胞中蛋白质53的扩散系数
J Biomater Nanobiotechnol. 2010 Oct;1(1):31-36. doi: 10.4236/jbnb.2010.11004.
2
Topoisomerase I inhibitors and drug resistance.拓扑异构酶 I 抑制剂与耐药性。
Cytotechnology. 1998 Sep;27(1-3):149-64. doi: 10.1023/A:1008008719699.
3
Etoposide induces heritable chromosomal aberrations and aneuploidy during male meiosis in the mouse.依托泊苷在小鼠雄性减数分裂过程中诱导可遗传的染色体畸变和非整倍体。
Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):3952-7. doi: 10.1073/pnas.061404598. Epub 2001 Mar 13.
4
Topoisomerase II-mediated alterations of K562 drug resistant sublines.拓扑异构酶II介导的K562耐药亚系的改变。
Med Oncol. 1999 Sep;16(3):191-8. doi: 10.1007/BF02906131.
5
The distribution of topoisomerase II on mammalian chromosomes.拓扑异构酶II在哺乳动物染色体上的分布。
Chromosome Res. 1996 Jan;4(1):5-14. doi: 10.1007/BF02254938.
6
Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA.从人拓扑异构酶II cDNA中分离出诱导对拓扑异构酶II相互作用细胞毒性药物产生抗性的遗传抑制元件。
Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3231-5. doi: 10.1073/pnas.90.8.3231.
7
Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: a new class of bioreductive agent.将细胞毒性蒽醌类脂肪族氮氧化物用作前药DNA结合剂的原理:一类新型生物还原剂。
Cancer Metastasis Rev. 1993 Jun;12(2):119-34. doi: 10.1007/BF00689805.
8
DNA fragmentation as a consequence of cell cycle traverse in doxorubicin- and idarubicin-treated human lymphoma cells.在多柔比星和伊达比星处理的人淋巴瘤细胞中,细胞周期进程导致的DNA片段化。
Ann Hematol. 1994;69 Suppl 1:S7-11. doi: 10.1007/BF01757348.
9
Identification of the aminocatechol A-3253 as an in vitro poison of DNA topoisomerase I from Candida albicans.鉴定氨基儿茶酚A-3253为白色念珠菌DNA拓扑异构酶I的体外毒素。
Antimicrob Agents Chemother. 1995 Mar;39(3):586-92. doi: 10.1128/AAC.39.3.586.
10
Topoisomerase I in multiple drug resistance.多药耐药中的拓扑异构酶I
Cytotechnology. 1993;12(1-3):127-35. doi: 10.1007/BF00744661.